Chikungunya vaccine
VACCINE TYPE
- IXCHIQ® is an attenuated live vaccine from the chikungunya virus (CHIKV) generated from the La Réunion strain and propagated from Vero cells.
- Available for adults 18 years of age and older who are determined to be at increased risk of exposure to chikungunya infection.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 7, 2024
Citation
Soto, Caitlin. "Chikungunya Vaccine." Johns Hopkins ABX Guide, The Johns Hopkins University, 2024. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540789/all/Chikungunya_vaccine.
Soto C. Chikungunya vaccine. Johns Hopkins ABX Guide. The Johns Hopkins University; 2024. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540789/all/Chikungunya_vaccine. Accessed December 18, 2024.
Soto, C. (2024). Chikungunya vaccine. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540789/all/Chikungunya_vaccine
Soto C. Chikungunya Vaccine [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2024. [cited 2024 December 18]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540789/all/Chikungunya_vaccine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Chikungunya vaccine
ID - 540789
A1 - Soto,Caitlin,PharmD, BCIDP
Y1 - 2024/01/07/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540789/all/Chikungunya_vaccine
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -